Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization

Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization

Age-related macular degeneration (AMD) is the primary cause of blindness in advanced countries. Repeated intravitreal delivery of anti-vascular endothelial growth factor (VEGF) agents has represented an important advancement for the therapy of wet AMD with significative results in terms of blindness...

Full description

Bibliographic Details
Main Authors: Valeria Tarallo, Emanuela Iaccarino, Valeria Cicatiello, Riccardo Sanna, Menotti Ruvo, Sandro De Falco
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:International Journal of Molecular Sciences
Subjects:
amd
cnv
vegfr1
multimeric peptides
oral delivery
Online Access:https://www.mdpi.com/1422-0067/21/2/410

Internet

https://www.mdpi.com/1422-0067/21/2/410

Similar Items